New combo therapy aims to keep lung cancer from returning after surgery
NCT ID NCT06624059
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times
Summary
This study looks at whether adding the targeted drug alectinib to standard chemotherapy is safe for people with a certain type of lung cancer (ALK-positive non-small cell lung cancer) after they have had surgery to remove the tumor. The trial involves 11 participants with stage II to IIIB disease. The main goal is to check for side effects, not to prove the treatment works long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia
Perugia, Umbria, 06156, Italy
-
Beijing Cancer Hospital
Beijing, 100142, China
-
Guangdong General Hospital
Guangzhou, 510000, China
-
Instituto do Cancer do Estado de Sao Paulo - ICESP
São Paulo, São Paulo, 01246-000, Brazil
-
Jinhua municipal central hospital
Jinhua, China
-
RedSalud Vitacura
Santiago, Chile
-
Royal North Shore Hospital
St Leonards, New South Wales, 2065, Australia
-
Sir Charles Gairdner Hospital
Nedlands, Western Australia, 6009, Australia
-
The third people's hospital of Chengdu
Chengdu, China
-
Yunnan Cancer Hospital
Kunming, 650118, China
Conditions
Explore the condition pages connected to this study.